Alerce Investment Management, L.P. is an investment fund managing more than $51 billion ran by Muneer Satter. There are currently 5 companies in Mr. Satter’s portfolio. The largest investments include Annexon Inc and Akebia Therapeutics, together worth $42.2 billion.
As of 7th August 2024, Alerce Investment Management, L.P.’s top holding is 7,406,024 shares of Annexon Inc currently worth over $36.3 billion and making up 71.1% of the portfolio value.
In addition, the fund holds 5,747,906 shares of Akebia Therapeutics worth $5.86 billion, whose value fell 12.4% in the past six months.
The third-largest holding is American Well Corp worth $3.4 billion and the next is Verona Pharma Plc worth $3.08 billion, with 213,000 shares owned.
Currently, Alerce Investment Management, L.P.'s portfolio is worth at least $51 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Alerce Investment Management, L.P. office and employees reside in Chicago, Illinois. According to the last 13-F report filed with the SEC, Muneer Satter serves as the Trustee of Managing Mbr of GP of Alerce Investment Managemen at Alerce Investment Management, L.P..
In the most recent 13F filing, Alerce Investment Management, L.P. revealed that it had opened a new position in
Verona Pharma Plc and bought 213,000 shares worth $3.08 billion.
On the other hand, there are companies that Alerce Investment Management, L.P. is getting rid of from its portfolio.
Alerce Investment Management, L.P. closed its position in Aileron Therapeutics Inc on 14th August 2024.
It sold the previously owned 830,466 shares for $5.51 billion.
Muneer Satter also disclosed a decreased stake in Akebia Therapeutics by 0.6%.
This leaves the value of the investment at $5.86 billion and 5,747,906 shares.
The two most similar investment funds to Alerce Investment Management, L.P. are Velt Partners Investimentos Ltda and Sonen Capital. They manage $51.1 billion and $50.9 billion respectively.
Alerce Investment Management, L.P.’s portfolio is diversified across 2 sectors.
Currently, their heaviest sector is Health Care — making up 24.2% of
the total portfolio value.
The fund focuses on investments in the United States as
40.0% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are small-cap stocks.
Stocks with a size of more than $100 million in market cap make up
20% of the total holdings value.
On the other hand, large-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $660 million.
These positions were updated on August 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Annexon Inc |
No change
7,406,024
|
$36,289,518,000 | 71.13% |
| Akebia Therapeutics Inc. |
56.47%
5,747,906
|
$5,862,864,000 | 11.49% |
| Aileron Therapeutics Inc |
Closed
830,466
|
$5,505,990,000 | |
| American Well Corp |
No change
10,475,717
|
$3,402,513,000 | 6.67% |
| Verona Pharma Plc |
Opened
213,000
|
$3,079,980,000 | 6.04% |
| Aadi Bioscience Inc |
No change
1,630,830
|
$2,381,012,000 | 4.67% |
| No transactions found | |||
| Showing first 500 out of 6 holdings | |||